INTERPRETING SURVIVAL RATES FOR THE TREATMENT OF DECOMPENSATED DIABETES: ARE WE SAVING TOO MANY LIVES?
- 1 November 1987
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 330 (8569) , 1192-1195
- https://doi.org/10.1016/s0140-6736(87)91330-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- CLINICAL, IMMUNOLOGICAL, AND VIROLOGICAL EFFECTS OF AMPLIGEN, A MISMATCHED DOUBLE-STRANDED RNA, IN PATIENTS WITH AIDS OR AIDS-RELATED COMPLEXThe Lancet, 1987
- Interferons and Their Clinical ValueClinical Infectious Diseases, 1987
- INTERFERON FOR THE TREATMENT OF INFECTIONSAnnual Review of Medicine, 1987
- Prevention of Natural Colds by Contact Prophylaxis with Intranasal Alpha2-InterferonNew England Journal of Medicine, 1986
- Prophylactic Efficacy of Intranasal Alpha2-Interferon against Rhinovirus Infections in the Family SettingNew England Journal of Medicine, 1986
- Lassa FeverNew England Journal of Medicine, 1986
- Ribavirin: beginning the blitz on respiratory viruses?The Pediatric Infectious Disease Journal, 1985
- Intravenous Foscarnet for the Treatment of Severe Cytomegalovirus Infection in Allograft RecipientsScandinavian Journal of Infectious Diseases, 1985